Table of Contents Author Guidelines Submit a Manuscript
Canadian Journal of Gastroenterology and Hepatology
Volume 2019, Article ID 6963910, 6 pages
https://doi.org/10.1155/2019/6963910
Research Article

High Prevalence of Multidrug Resistant Bacteria in Cirrhotic Patients with Spontaneous Bacterial Peritonitis: Is It Time to Change the Standard Antimicrobial Approach?

1Post-Graduate Program in Gastroenterology and Hepatology, Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil
2World Gastroenterology Organization Porto Alegre Training Center, Porto Alegre, Brazil
3Infectious Disease Control Commission, Hospital de Clínicas de Porto Alegre, Porto Alegre, Brazil
4Division of Gastroenterology and Hepatology, Hospital de Clínicas de Porto Alegre, Porto Alegre, Brazil

Correspondence should be addressed to Jerônimo De Conto Oliveira; moc.liamg@ocdominorej

Received 9 January 2019; Revised 20 March 2019; Accepted 3 April 2019; Published 13 May 2019

Guest Editor: Eduardo G. Vilela

Copyright © 2019 Jerônimo De Conto Oliveira et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. E. Strauss, “The impact of bacterial infections on survival of patients with decompensated cirrhosis,” Annals of Hepatology, vol. 13, no. 1, pp. 7–19, 2014. View at Publisher · View at Google Scholar
  2. X. Ariza, J. Castellote, J. Lora-Tamayo et al., “Risk factors for resistance to ceftriaxone and its impact on mortality in community, healthcare and nosocomial spontaneous bacterial peritonitis,” Journal of Hepatology, vol. 56, no. 4, pp. 825–832, 2012. View at Publisher · View at Google Scholar
  3. J. Fernandez, J. Acevedo, M. Castro et al., “Prevalence and risk factors of infections by multiresistant bacteria in cirrhosis: a prospective study,” Hepatology, vol. 55, no. 5, pp. 1551–1561, 2012. View at Publisher · View at Google Scholar · View at Scopus
  4. A. M. Oliveira, J. C. Branco, R. Barosa et al., “Clinical and microbiological characteristics associated with mortality in spontaneous bacterial peritonitis: a multicenter cohort study,” European Journal of Gastroenterology & Hepatology, vol. 28, no. 10, pp. 1216–1222, 2016. View at Publisher · View at Google Scholar
  5. A. M. Costabeber, A. A. Mattos, and T. C. T. Sukiennik, “Prevalence of bacterial resistance in hospitalized cirrhotic patients in southern brazil: a new challenge,” Revista do Instituto de Medicina Tropical de São Paulo, vol. 58, no. 1, pp. 1–7, 2016. View at Publisher · View at Google Scholar
  6. F. Salerno, M. Borzio, C. Pedicino et al., “The impact of infection by multidrug-resistant agents in patients with cirrhosis. A multicenter prospective study,” Liver International, vol. 37, no. 1, pp. 71–79, 2017. View at Publisher · View at Google Scholar
  7. R. C. Oey, R. A. de Man, N. S. Erler, A. Verbon, and H. R. van Buuren, “Microbiology and antibiotic susceptibility patterns in spontaneous bacterial peritonitis: a study of two Dutch cohorts at a 10-year interval,” United European Gastroenterology Journal, vol. 6, no. 4, pp. 614–621, 2018. View at Publisher · View at Google Scholar
  8. P. R. Almeida, G. S. Leão, C. D. Gonçalves, R. V. Picon, and C. V. Tovo, “Impact of microbiological changes on spontaneous bacterial peritonitis in three different periods over 17 years,” Arquivos de Gastroenterologia, vol. 55, no. 1, pp. 23–27, 2018. View at Publisher · View at Google Scholar
  9. J. Fernández, M. Navasa, J. Gómez et al., “Bacterial infections in cirrhosis: epidemiological changes with invasive procedures and norfloxacin prophylaxis,” Hepatology, vol. 35, no. 1, pp. 140–148, 2002. View at Publisher · View at Google Scholar · View at Scopus
  10. A. Rimola, G. García-Tsao, M. Navasa et al., “Diagnosis, treatment and prophylaxis of spontaneous bacterial peritonitis: a consensus document,” Journal of Hepatology, vol. 32, no. 1, pp. 142–153, 2000. View at Publisher · View at Google Scholar
  11. P. Angeli, M. Bernardi, C. Villanueva et al., “EASL clinical practice guidelines for the management of patients with decompensated cirrhosis,” Journal of Hepatology, vol. 69, no. 2, pp. 406–460, 2018. View at Publisher · View at Google Scholar
  12. J. B. Dever and M. Y. Sheikh, “Review article: spontaneous bacterial peritonitis-bacteriology, diagnosis, treatment, risk factors and prevention,” Alimentary Pharmacology & Therapeutics, vol. 41, no. 11, pp. 1116–1131, 2015. View at Publisher · View at Google Scholar · View at Scopus
  13. B. A. Runyon, “Introduction to the revised american association for the study of liver diseases practice guideline management of adult patients with ascites due to cirrhosis 2012,” Hepatology, vol. 57, no. 4, pp. 1651–1653, 2013. View at Publisher · View at Google Scholar · View at Scopus
  14. A.-P. Magiorakos, A. Srinivasan, R. B. Carey et al., “Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance,” Clinical Microbiology and Infection, vol. 18, no. 3, pp. 268–281, 2012. View at Publisher · View at Google Scholar · View at Scopus
  15. E. von Elm, M. Egger, Initiative. Strobe et al., “Strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies,” Revista Española de Salud Pública, vol. 82, pp. 251–259, 2008. View at Publisher · View at Google Scholar · View at Scopus
  16. R. Moreau, L. Elkrief, C. Bureau et al., “Effects of long-term norfloxacin therapy in patients with advanced cirrhosis,” Gastroenterology, vol. 155, no. 6, pp. 1816–1827.e9, 2018. View at Publisher · View at Google Scholar
  17. L. Kamani, K. Mumtaz, U. S. Ahmed, A. W. Ali, and W. Jafri, “Outcomes in culture positive and culture negative ascitic fluid infection in patients with viral cirrhosis: cohort study,” BMC Gastroenterology, vol. 8, no. 1, pp. 1–6, 2008. View at Publisher · View at Google Scholar
  18. A. K. Sofjan, R. J. Musgrove, N. D. Beyda et al., “Prevalence and predictors of spontaneous bacterial peritonitis due to ceftriaxone-resistant organisms at a large tertiary centre in the USA,” Journal of Global Antimicrobial Resistance, vol. 15, pp. 41–47, 2018. View at Publisher · View at Google Scholar
  19. S. Piano, V. Singh, P. Caraceni, R. Maiwall, C. Alessandria, J. Fernandez et al., “Epidemiology and effects of bacterial infections in patients with cirrhosis worldwide,” Gastroenterology, vol. 156, no. 5, pp. 1368–1380.e10, 2019. View at Publisher · View at Google Scholar
  20. M. Fiore, I. Gentile, A. E. Maraolo et al., “Are third-generation cephalosporins still the empirical antibiotic treatment of community-acquired spontaneous bacterial peritonitis? A systematic review and meta-analysis,” European Journal of Gastroenterology & Hepatology, vol. 30, no. 3, pp. 329–336, 2018. View at Publisher · View at Google Scholar